
Bhavana Pothuri MD
Gynecologic Oncology
Professor, Obstetrics & Gynecology, New York University School of Medicine Director, Gynecologic Oncology Clinical Trials
Join to View Full Profile
160 E 34th StNew York, NY 10016
Phone+1 212-731-6455
Fax+1 212-731-5600
Dr. Pothuri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bhavana Pothuri is an Obstetrics and Gynecology specialist with a subspecialty in Gynecologic Oncology, based in New York, NY. She completed her medical education at Sidney Kimmel Medical College, followed by a residency in Obstetrics and Gynecology at Main Line Health System/Lankenau Medical Center, and a fellowship in Gynecologic Oncology at Memorial Sloan Kettering Cancer Center. Dr. Pothuri is a professor at New York University School of Medicine and has extensive experience in ovarian neoplasms, fallopian tube carcinoma, and robotic gynecologic surgery. Her research has led to numerous publications on topics such as ovarian cancer treatments and clinical trial diversity. She has participated in clinical trials focusing on various gynecologic cancers and has been recognized as a top doctor in the New York Metro Area. Dr. Pothuri is a Fellow of the American Congress of Obstetricians and Gynecologists.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Gynecologic Oncology, 1999 - 2003
- Main Line Health System/Lankenau Medical CenterResidency, Obstetrics and Gynecology, 1995 - 1999
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995
Certifications & Licensure
- NY State Medical License 2000 - 2025
- PA State Medical License 1996 - 2002
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- NY Magazine Top Doctors 2018
- Top Doctors: New York Metro Area Castle Connolly, 2014-2018
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer Start of enrollment: 2010 Jun 01
- Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors Start of enrollment: 2016 Mar 07
- Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2017 Jun 23
- Join now to see all
Publications & Presentations
PubMed
- Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability.Bradley R Corr, Samantha M Thomas, Paulina J Haight, Elizabeth Stock, Jessica Floyd
Gynecologic Oncology. 2025-08-14 - HER2 expression in an endometrial cancer cohort.Kari E Hacker, Kathryn A Fleming, Mamta Gupta, Bhavana Pothuri
Gynecologic Oncology. 2025-08-05 - Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with d...Dana M Chase, Jørn Herrstedt, Eirwen M Miller, Lucy Gilbert, Oleksandr Zub
International Journal of Gynecological Cancer. 2025-08-01
Authored Content
- Articles & IssuesDecember 2018
Press Mentions
- What Can We Do About Health Disparities in the Diagnosis and Treatment of Endometrial Cancer?August 27th, 2024
- Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial CancerMay 11th, 2023
- Remove Fallopian Tubes to Prevent Ovarian Cancer, Research Group SaysFebruary 3rd, 2023
- Join now to see all
Committees
- Co-Chair, SGO COVID Task Force 2020 - Present
- Co-Chair, SGO COVID Task Force 2020 - Present
- Co-Chair, SGO COVID Task Force 2020 - Present
- Vice Chair, SGO Clinical Practice Committee 2018 - Present
- Secretary, NYU Langone Health Faculty Council 2018 - Present
- Co-Chair, SGO COVID Task Force 2020 - 2020
- Co-Chair, SGO COVID Task Force 2020 - 2020
- Co-Chair, SGO COVID Task Force 2020 - 2020
Professional Memberships
- Member
- Society of Gynecologic OncologyMember
- NY Obstetrical SocietyMember
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: